These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 25293804)

  • 21. Intratumor heterogeneity: models of malignancy emergence and evolution.
    Ivanov RA; Lashin SA
    Vavilovskii Zhurnal Genet Selektsii; 2023 Dec; 27(7):815-819. PubMed ID: 38213707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phylogenetic and epidemic modeling of rapidly evolving infectious diseases.
    Kühnert D; Wu CH; Drummond AJ
    Infect Genet Evol; 2011 Dec; 11(8):1825-41. PubMed ID: 21906695
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer in light of experimental evolution.
    Sprouffske K; Merlo LM; Gerrish PJ; Maley CC; Sniegowski PD
    Curr Biol; 2012 Sep; 22(17):R762-71. PubMed ID: 22975007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inferring Tumor Proliferative Organization from Phylogenetic Tree Measures in a Computational Model.
    Scott JG; Maini PK; Anderson ARA; Fletcher AG
    Syst Biol; 2020 Jul; 69(4):623-637. PubMed ID: 31665523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Computational Methods for Analysis of Tumor Clonality and Evolutionary History.
    Goh G; McGranahan N; Wilson GA
    Methods Mol Biol; 2019; 1878():217-226. PubMed ID: 30378079
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modeling tumor evolutionary dynamics.
    Stransky B; de Souza SJ
    Front Physiol; 2012; 3():480. PubMed ID: 23420281
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lymph Node Metastases in Colon Cancer Are Polyclonal.
    Ulintz PJ; Greenson JK; Wu R; Fearon ER; Hardiman KM
    Clin Cancer Res; 2018 May; 24(9):2214-2224. PubMed ID: 29203589
    [No Abstract]   [Full Text] [Related]  

  • 28. Defining order and timing of mutations during cancer progression: the TO-DAG probabilistic graphical model.
    Lecca P; Casiraghi N; Demichelis F
    Front Genet; 2015; 6():309. PubMed ID: 26528329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Cumulative Indel Model: Fast and Accurate Statistical Evolutionary Alignment.
    De Maio N
    Syst Biol; 2021 Feb; 70(2):236-257. PubMed ID: 32653921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evolution in Mind: Evolutionary Dynamics, Cognitive Processes, and Bayesian Inference.
    Suchow JW; Bourgin DD; Griffiths TL
    Trends Cogn Sci; 2017 Jul; 21(7):522-530. PubMed ID: 28551106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Every which way? On predicting tumor evolution using cancer progression models.
    Diaz-Uriarte R; Vasallo C
    PLoS Comput Biol; 2019 Aug; 15(8):e1007246. PubMed ID: 31374072
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SubClonal Hierarchy Inference from Somatic Mutations: Automatic Reconstruction of Cancer Evolutionary Trees from Multi-region Next Generation Sequencing.
    Niknafs N; Beleva-Guthrie V; Naiman DQ; Karchin R
    PLoS Comput Biol; 2015 Oct; 11(10):e1004416. PubMed ID: 26436540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unraveling the Drivers of Tumorigenesis in the Context of Evolution: Theoretical Models and Bioinformatics Tools.
    Zhu X; Zhao W; Zhou Z; Gu X
    J Mol Evol; 2023 Aug; 91(4):405-423. PubMed ID: 37246992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comprehensive statistical inference of the clonal structure of cancer from multiple biopsies.
    Liu J; Halloran JT; Bilmes JA; Daza RM; Lee C; Mahen EM; Prunkard D; Song C; Blau S; Dorschner MO; Gadi VK; Shendure J; Blau CA; Noble WS
    Sci Rep; 2017 Dec; 7(1):16943. PubMed ID: 29208983
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stochastic modeling indicates that aging and somatic evolution in the hematopoetic system are driven by non-cell-autonomous processes.
    Rozhok AI; Salstrom JL; DeGregori J
    Aging (Albany NY); 2014 Dec; 6(12):1033-48. PubMed ID: 25564763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MesKit: a tool kit for dissecting cancer evolution of multi-region tumor biopsies through somatic alterations.
    Liu M; Chen J; Wang X; Wang C; Zhang X; Xie Y; Zuo Z; Ren J; Zhao Q
    Gigascience; 2021 May; 10(5):. PubMed ID: 34018555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identifying restrictions in the order of accumulation of mutations during tumor progression: effects of passengers, evolutionary models, and sampling.
    Diaz-Uriarte R
    BMC Bioinformatics; 2015 Feb; 16():41. PubMed ID: 25879190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessing the contribution of tumor mutational phenotypes to cancer progression risk.
    Tao Y; Rajaraman A; Cui X; Cui Z; Chen H; Zhao Y; Eaton J; Kim H; Ma J; Schwartz R
    PLoS Comput Biol; 2021 Mar; 17(3):e1008777. PubMed ID: 33711014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cancer immunoediting: A game theoretical approach.
    Tavakoli F; Sartakhti JS; Manshaei MH; Basanta D
    In Silico Biol; 2021; 14(1-2):1-12. PubMed ID: 33216021
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inference and Evolutionary Analysis of Genome-Scale Regulatory Networks in Large Phylogenies.
    Koch C; Konieczka J; Delorey T; Lyons A; Socha A; Davis K; Knaack SA; Thompson D; O'Shea EK; Regev A; Roy S
    Cell Syst; 2017 May; 4(5):543-558.e8. PubMed ID: 28544882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.